President and CEO Sanjeev Luther and Co-Chief Medical Officer Tim Pardee, M.D., Ph.D., will discuss clinical trial launches, FDA-granted Fast Track designations and other recent accomplishments on Wednesday, Jan. 20 President and CEO Sanjeev Luther and Co-Chief Medical Officer Tim Pardee, M.D., Ph.D., will discuss clinical trial launches, FDA-granted Fast Track designations and other recent accomplishments on Wednesday, Jan. 20

See the rest here:
Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor Conference

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh